Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma
Clinical trial NCT02833701 · TERMINATED
Trial details
- NCT number
- NCT02833701
- Sponsor
- University of Nebraska
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2019-03-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.